Adjuvant chemotherapy for adenocarcinoma of the colon in Cote-d'Or;Chimiotherapie adjuvante pour adenocarcinome colique dans le departement de la Cote-d'Or

Gastroenterologie Clinique et Biologique

Volumn 22, Issue 3, 1998, Pages 269-272

  Jouve, Jean Louis ^a   Mitry, Emmanuel ^a   Phelip, Jean Marc ^a   Villing, Anne Laure ^a   Tazi, Mohammed Adnane ^a   Faivre, Jean ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Adjuvant chemotherapy; Cancer registry; Colon adenocarcinoma; Dukes'C; Medical practices evaluation

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; COLORECTAL CARCINOMA; FRANCE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; TREATMENT PLANNING; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; AGE; COLON TUMOR; DEMOGRAPHY; FEMALE; HEALTH CARE DELIVERY; MALE; MIDDLE AGED; PATHOLOGY; REGISTER;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DELIVERY OF HEALTH CARE; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; RESIDENCE CHARACTERISTICS;

EID: 0031944540     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Launoy G, Soumrany A, Pottier D, Gignoux M. Etude de la diffusion des progrès thérapeutiques dans un registre de morbidité. Exemple du cancer du rectum dans le Calvados. Rev Epidemiol Sante Publique 1991;39:523-9
2. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil: the North Central Cancer treatment Group Mayo Clinic. J Clin Oncol 1989;7:1447-56.
3. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ et al. Levamisole and fluoro-uracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
4. Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G et al. Folinic acid and 5-fluoro-uracil as adjuvant chemotherapy in colon cancer. Gastroenterology 1994;106:899-906.
5. IMPACT Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345:939-44.
6. O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997;15:246-50.
7. Ducreux M, Rougier P. Traitement adjuvant des cancers colorectaux. Gastoenterol Clin Biol 1994;18:719-25.
8. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323.
9. International Classification of Diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. 9th ed. Washington: WHO, 1989.
10. BMDP Statistical Software Manual, Vol 2. Berkeley: University of California Press, 1992:1145-79.
11. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J. Survival of cancer patients in Europe. The EUROCARE Study. IARC Sci Public no 132, Lyon 1995.
12. Mayer RJ, O'Connell MJ, Tepper JE, Wolmark N. Status of adjuvant therapy for colorectal cancer. J Natl Cancer Inst 1989;81:1359-64
13. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM et al. Fluoro-uracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995;122:321-6.
14. Erlichman C, Marsoni S, Seitz JF, Skillings J, Shepard L, Zee B et al. Event free and overall survival is increased by FUFA in resected B colon cancer: a pooled analysis of five randomized trials (RCTS). Proc Am Soc Clin Oncol 1997;16:991.
15. Kerjan A, Fiche M, Gasser P, Le Bodic MF, Le Bodic L. La chimiothérapie adjuvante des cancers coliques: une pratique éloignée de la théorie (résumé). Gastroenterol Clin Biol 1994; 18:A 31.